Independent Drug Value Assessment Act of 2024
USA118th CongressHR-6977| House
| Updated: 1/12/2024
Jerrold Nadler
Democratic Representative
New York
Cosponsors (2)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Independent Drug Value Assessment Act of 2024
USA118th CongressHR-6977| House
| Updated: 1/12/2024
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Jerrold Nadler
Democratic Representative
New York